Fresenius Medical Care Sugarland, Llc is a medicare approved dialysis facility center in Sugar Land, Texas and it has 1 dialysis stations. It is located in Fort Bend county at 4675 Sweetwater Blvd., Suite B, Sugar Land, TX, 77479. You can reach out to the office of Fresenius Medical Care Sugarland, Llc at (281) 240-4076. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Sugarland, Llc has the following ownership type - Profit. It was first certified by medicare in August, 2017. The medicare id for this facility is 452927 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Sugarland, Llc |
|---|---|
| Location | 4675 Sweetwater Blvd., Suite B, Sugar Land, Texas |
| No. of Dialysis Stations | 1 |
| Medicare ID | 452927 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 4675 Sweetwater Blvd., Suite B, Sugar Land, Texas, 77479 | |
| (281) 240-4076 | |
| Not Available |
News Archive
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, today announced its financial results for the quarter ended December 31, 2012.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 3 days ago
| NPI Number | 1467838581 |
| Organization Name | Fresenius Medical Care Sugar Land |
| Doing Business As | Fresenius Medical Care Sugarland, Llc |
| Address | 1107 Soldiers Field Dr Sugar Land, Texas, 77479 |
| Phone Number | (281) 980-3470 |
News Archive
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, today announced its financial results for the quarter ended December 31, 2012.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 3 days ago
| NPI Number | 1639623556 |
| Organization Name | Fresenius Kidney Care Sugarland Home |
| Doing Business As | Fresenius Medical Care Sugarland, Llc |
| Address | 4675 Sweetwater Blvd Sugar Land, Texas, 77479 |
| Phone Number | (281) 240-4076 |
News Archive
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, today announced its financial results for the quarter ended December 31, 2012.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.